Curident launches gentler oral care for cancer patients

Curident has launched a disposable, one-step oral care system for cancer patients with mouth sores, dry mouth and sensitive tissue. The product debuted at ONS Congress 2026 and is now available online as the company seeks wider distribution in oncology and pharmacy channels.

Why it matters: - Oral side effects can make brushing painful for cancer patients and can affect comfort, nutrition and quality of life. - Curident is designed for patients with sensitive or compromised oral tissue and for caregivers who need a simple daily care option. - The product is intended to reduce bacterial exposure for immunocompromised users.

What happened: - Curident launched a patent-pending, one-step oral care system for people undergoing cancer treatment. - The product debuted last month at ONS Congress 2026 in San Antonio, Texas. - The launch came during National Cancer Survivors Month, when the company highlighted oral complications that affect one in three cancer patients during treatment. - Curident is now available directly to consumers and to caregivers.

The details: - The system is meant to be used with no preparation and no cleanup: wet, brush and dispose. - Curident is built from the team behind ReadyBrush, the disposable pre-pasted toothbrush. - Each brush uses ultra-soft, feathered PBT bristles. - The pre-pasted formula does not contain sodium lauryl sulfate or harsh mint flavoring. - The product includes aloe barbadensis, chamomile and calendula. - Hydroxyapatite is included to help strengthen and remineralize enamel. - Xylitol is included for moisture support, and eugenol is included to help ease oral discomfort. - The brush uses a gentle tutti-frutti flavor for mouths that can no longer tolerate mint. - The single-use disposable format is meant to reduce bacterial exposure. - Curident is available in 10-pack, 30-pack, 72-pack and 144-pack sizes. - First-time buyers and subscribers can access discounted options at curident.com. - Curident is FDA-registered, ISO 9001-certified, made in the USA and independently third-party laboratory tested.

Between the lines: - Curident is aiming at a niche where standard toothbrushes can become painful and impractical during treatment. - The product is positioned as both a clinical comfort item and a practical caregiver gift. - The company is also trying to build a distribution network around oncology centers, hospitals, pharmacies and specialty retail. - Nancy Mantell, Curident co-founder, said brushing can become a painful, dreaded moment for cancer patients and caregivers. - Curident says it developed the product with chemists, oncology nurses and dental professionals.

What's next: - Curident is seeking authorized distribution partners nationwide. - Qualified distributors serving oncology centers, hospitals, pharmacies and specialty retail markets are being invited to connect with the company. - Media, partnership and distributor inquiries go to support@curident.com or media@curident.com. - Curident says the product is not intended to diagnose, treat, cure or prevent any disease.

The bottom line: - Curident is betting that a simple disposable brush can solve a daily pain point for cancer patients and their caregivers.